Literature DB >> 15162426

Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells.

Eleanor Barnes1, Scott M Ward, Victoria O Kasprowicz, Geoffrey Dusheiko, Paul Klenerman, Michaela Lucas.   

Abstract

A major breakthrough in cellular immunology has been the development of HLA class I tetramers to analyze CD8(+) T cell responses. However, in many situations, including persistent virus infection, specific T cell responses are rarely detected using this technology. This raises the question of whether such responses are 'deleted' (or 'exhausted') or present below the conventional detection limit for class I tetramer staining. In particular, persistent hepatitis C virus (HCV) infection is characterized by very weak or apparently absent specific CD8(+) T cell responses, even though they are readily detectable in acute disease. Therefore, we assessed the use of anti-PE-labeled magnetic beads to enrich tetramer-positive HCV-specific T cells and identify previously undetectable populations. Using the enrichment technique, HCV-specific T cells could be detected in the majority of infected individuals, whereas these responses were not detected using conventional tetramer staining (8/15 vs. 1/15; p=0.01). Magnetic enrichment could reliably detect very rare HCV-specific responses at frequencies of >0.0011% of CD8(+) T cells (approximately 1/million PBMC), and phenotypic analysis of these rare populations was possible. Therefore, this direct ex vivo technique revealed the persistence of very low frequencies of virus-specific CD8(+) T cells during chronic virus infection and is readily transferable to the study of other viral, self- or tumor-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162426     DOI: 10.1002/eji.200424898

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

2.  HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Authors:  Thomas J Scriba; Hua-Tang Zhang; Helen L Brown; Annette Oxenius; Norbert Tamm; Sarah Fidler; Julie Fox; Jonathan N Weber; Paul Klenerman; Cheryl L Day; Michaela Lucas; Rodney E Phillips
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ).

Authors:  Cecilia S Lindestam Arlehamn; John Sidney; Ryan Henderson; Jason A Greenbaum; Eddie A James; Magdalini Moutaftsi; Rhea Coler; Denise M McKinney; Daniel Park; Randy Taplitz; William W Kwok; Howard Grey; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

4.  Human CD8⁺ and CD4⁺ T cell memory to lymphocytic choriomeningitis virus infection.

Authors:  Maya F Kotturi; Justine A Swann; Bjoern Peters; Cecilia Lindestam Arlehamn; John Sidney; Ravi V Kolla; Eddie A James; Rama S Akondy; Rafi Ahmed; William W Kwok; Michael J Buchmeier; Alessandro Sette
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

5.  Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.

Authors:  Gerald Willimsky; Karin Schmidt; Christoph Loddenkemper; Johanna Gellermann; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

6.  Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.

Authors:  Ian A Cockburn; Yun-Chi Chen; Michael G Overstreet; Jason R Lees; Nico van Rooijen; Donna L Farber; Fidel Zavala
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

7.  CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.

Authors:  Matthew Hoare; William T H Gelson; Abhi Das; Jean M Fletcher; Susan E Davies; Martin D Curran; Sarah L Vowler; Mala K Maini; Arne N Akbar; Graeme J M Alexander
Journal:  J Hepatol       Date:  2010-04-22       Impact factor: 25.083

8.  Tracking epitope-specific T cells.

Authors:  James J Moon; H Hamlet Chu; Jason Hataye; Antonio J Pagán; Marion Pepper; James B McLachlan; Traci Zell; Marc K Jenkins
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 9.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity.

Authors:  Ludmila Danilova; Valsamo Anagnostou; Franck Housseau; Kellie N Smith; Justina X Caushi; John-William Sidhom; Haidan Guo; Hok Yee Chan; Prerna Suri; Ada Tam; Jiajia Zhang; Margueritta El Asmar; Kristen A Marrone; Jarushka Naidoo; Julie R Brahmer; Patrick M Forde; Alexander S Baras; Leslie Cope; Victor E Velculescu; Drew M Pardoll
Journal:  Cancer Immunol Res       Date:  2018-06-12       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.